Literature DB >> 18953445

Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

Michael Sia1, Tom Pickles, Gerard Morton, Louis Souhami, Himu Lukka, Padraig Warde.   

Abstract

For patients with recurrent prostate cancer after radical prostatectomy, salvage radiotherapy is the only potentially curative treatment option. However, until recently there has been a paucity of data on the effectiveness of this approach. In light of recently published studies, the Genito-Urinary Radiation Oncologists of Canada (GUROC) met and crafted a consensus statement regarding the current place of salvage radiotherapy. GUROC also identified gaps in current knowledge and identified ongoing study protocols that will advance our knowledge in this area.This report summarizes the main conclusions of the meeting and the commentary provided during the consensus-building process, and outlines the consensus statement that was subsequently adopted.

Entities:  

Year:  2008        PMID: 18953445      PMCID: PMC2572238          DOI: 10.5489/cuaj.916

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  42 in total

1.  Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors.

Authors:  Joseph P Brooks; Paul S Albert; Richard B Wilder; Dean A Gant; David G McLeod; Matthew M Poggi
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

2.  Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.

Authors:  Raymond Miralbell; Hansjörg Vees; Joan Lozano; Haleem Khan; Meritxell Mollà; Alberto Hidalgo; Dolors Linero; Michel Rouzaud
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

3.  Adjuvant radiotherapy following radical prostatectomy: Genito-Urinary Radiation Oncologists of Canada Consensus Statement.

Authors:  Tom Pickles; Scott Morgan; Gerard Morton; Louis Souhami; Padraig Warde; Himu Lukka
Journal:  Can Urol Assoc J       Date:  2008-04       Impact factor: 1.862

4.  Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.

Authors:  Steven J Buskirk; Thomas M Pisansky; Steven E Schild; O Kenneth Macdonald; Michael J Wehle; Timothy F Kozelsky; A Craig Collie; Robert G Ferrigni; Robert P Myers; Karin A Prussak; Michael G Heckman; Julia E Crook; Alexander S Parker; Todd C Igel
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

5.  Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Authors:  Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

6.  Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates.

Authors:  Joseph F Pazona; Misop Han; Sheila A Hawkins; Kimberly A Roehl; William J Catalona
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

7.  Radiation rescue for biochemical failure after surgery for prostate cancer: predictive parameters and an assessment of contemporary predictive models.

Authors:  Zvi Symon; Yulia Kundel; Siegal Sadetzki; Bernice Oberman; Jacob Ramon; Menachem Laufer; Raphael Catane; M Raphael Pfeffer
Journal:  Am J Clin Oncol       Date:  2006-10       Impact factor: 2.339

Review 8.  The significance of recurrent PSA after radical prostatectomy: benign versus malignant sources.

Authors:  V Ravery
Journal:  Semin Urol Oncol       Date:  1999-08

9.  Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns.

Authors:  D M Nudell; G D Grossfeld; V K Weinberg; M Roach; P R Carroll
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

10.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

View more
  9 in total

1.  Radiation therapy in prostate cancer: a risk-adapted strategy.

Authors:  A J Hayden; C Catton; T Pickles
Journal:  Curr Oncol       Date:  2010-09       Impact factor: 3.677

2.  Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy.

Authors:  Naresh Regula; Michael Häggman; Silvia Johansson; Jens Sörensen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-08       Impact factor: 9.236

3.  Clarifying the role of salvage radiotherapy.

Authors:  Joseph Chin
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

4. 

Authors:  Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

5.  Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.

Authors:  Oladunni O Akin-Akintayo; Ashesh B Jani; Oluwaseun Odewole; Funmilayo I Tade; Peter T Nieh; Viraj A Master; Leah M Bellamy; Raghuveer K Halkar; Chao Zhang; Zhengjia Chen; Mark M Goodman; David M Schuster
Journal:  Clin Nucl Med       Date:  2017-01       Impact factor: 7.794

6.  The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia.

Authors:  Scott Tyldesley; Michael Peacock; James W Morris; Alan So; Charmaine Kim-Sing; Jill Quirt; Michael Carter; Tom Pickles
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

7.  Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

Authors:  David H Wilson; David W Hanlon; Gail K Provuncher; Lei Chang; Linan Song; Purvish P Patel; Evan P Ferrell; Herbert Lepor; Alan W Partin; Dan W Chan; Lori J Sokoll; Carol D Cheli; Robert P Thiel; David R Fournier; David C Duffy
Journal:  Clin Chem       Date:  2011-10-13       Impact factor: 8.327

8.  Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study.

Authors:  Makito Miyake; Nobumichi Tanaka; Isao Asakawa; Yosuke Morizawa; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Tatsuo Yoneda; Masatoshi Hasegawa; Noboru Konishi; Kiyohide Fujimoto
Journal:  Radiat Oncol       Date:  2014-10-20       Impact factor: 3.481

9.  The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions.

Authors:  Makito Miyake; Nobumichi Tanaka; Isao Asakawa; Takuya Owari; Shunta Hori; Yosuke Morizawa; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Kazumasa Torimoto; Masatoshi Hasegawa; Tomomi Fujii; Noboru Konishi; Kiyohide Fujimoto
Journal:  Prostate Int       Date:  2018-05-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.